Updates on cervical cancer prevention
D Viveros-Carreño, A Fernandes… - International Journal of …, 2023 - ijgc.bmj.com
In 2020, approximately 604 127 patients were newly diagnosed with cervical cancer and
341 831 died of the disease worldwide. Unfortunately, 85–90% of new cases and deaths …
341 831 died of the disease worldwide. Unfortunately, 85–90% of new cases and deaths …
HPV vaccine: updates and highlights
CM De Oliveira, JHTG Fregnani, LL Villa - Acta cytologica, 2019 - karger.com
HPV is the most common sexually transmitted biological agent and is the cause of many
conditions in men and women, including precancer lesions and cancer. Three prophylactic …
conditions in men and women, including precancer lesions and cancer. Three prophylactic …
[HTML][HTML] Basic research on curcumin in cervical cancer: Progress and perspectives
X Zhang, L Zhu, X Wang, H Zhang, L Wang… - Biomedicine & …, 2023 - Elsevier
Curcumin is a polyphenolic substance extracted from plants such as Curcuma longa,
Curcuma zedoaria, and radix curcumae, and it has attracted much attention because of the …
Curcuma zedoaria, and radix curcumae, and it has attracted much attention because of the …
Safety profile of the 9-valent HPV vaccine: a combined analysis of 7 phase III clinical trials
ED Moreira, SL Block, D Ferris, AR Giuliano… - …, 2016 - publications.aap.org
OBJECTIVES: The overall safety profile of the 9-valent human papillomavirus (9vHPV)
vaccine was evaluated across 7 Phase III studies, conducted in males and females …
vaccine was evaluated across 7 Phase III studies, conducted in males and females …
Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm
Since being introduced in the 1940s, cervical cytology–despite its limitations–has had
unequivocal success in reducing cervical cancer burden in many countries. However, we …
unequivocal success in reducing cervical cancer burden in many countries. However, we …
A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix
Background There remains uncertainty about the role of human papillomavirus (HPV)
infection in causing small-cell neuroendocrine carcinoma (SCNC) and large-cell …
infection in causing small-cell neuroendocrine carcinoma (SCNC) and large-cell …
Immunogenicity and safety of a 9-valent HPV vaccine
P Van Damme, SE Olsson, S Block… - …, 2015 - publications.aap.org
OBJECTIVES: Prophylactic vaccination of youngwomen aged 16 to 26 years with the 9-
valent (6/11/16/18/31/33/45/52/58) human papillomavirus (HPV) virus-like particle (9vHPV) …
valent (6/11/16/18/31/33/45/52/58) human papillomavirus (HPV) virus-like particle (9vHPV) …
Protecting people with multiple sclerosis through vaccination
Vaccination is one of the most effective and cost-efficient methods for protecting people with
multiple sclerosis (MS) from infections. However, use of vaccines has often been …
multiple sclerosis (MS) from infections. However, use of vaccines has often been …
Strategies for screening and early detection of anal cancers: a narrative and systematic review and meta‐analysis of cytology, HPV testing, and other biomarkers
MA Clarke, N Wentzensen - Cancer cytopathology, 2018 - Wiley Online Library
Anal cancer incidence and mortality have been increasing over the past decade. Although
the incidence in the general population remains low, it is much higher in certain subgroups …
the incidence in the general population remains low, it is much higher in certain subgroups …
Optimal treatment in locally advanced cervical cancer
C Gennigens, M De Cuypere, J Hermesse… - Expert Review of …, 2021 - Taylor & Francis
Introduction: Locally advanced cervical cancer (LACC)(International Federation of
Gynecology and Obstetrics (FIGO) 2009/2018–stages IB2-IVA/IB3-IVA, respectively) is …
Gynecology and Obstetrics (FIGO) 2009/2018–stages IB2-IVA/IB3-IVA, respectively) is …